Success Stories: Postdoctoral Research Fellow from India in the Field of Protein Biochemistry Secures an EB-1A Petition Approval the Second Time Around with 121 Citations

Client’s Testimonial:

“Thank you very much for the efforts and time to put this application. Sincere thanks to Victoria Chen, other immigration attorneys and your office staff for handling my application. Relieved!”

On September 2^nd, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Fellow in the Field of Protein Biochemistry (Approval Notice).

General Field: Protein Biochemistry

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: India

Service Center: Texas Service Center (TSC)

Approval Notice Date: September 2^nd, 2016

Processing Time: 7 months, 13 days

Case Summary:

With a Ph.D. and research experience in the field of protein biochemistry, this postdoctoral research fellow from India had suitable credentials to file his I-140 petition under the EB-1A (Alien of Extraordinary Ability) visa category. This is not his first try at obtaining an EB-1A petition approval. He engaged our services several years ago to help him file both an EB-1A and EB-2 NIW (National Interest Waiver) petition. Although his EB-2 NIW petition was approved, his EB-1A petition was ultimately denied. This was a disappointment to us as an EB-1A approval would have allowed our client to adjust his status for permanent residence without waiting two more years for his priority date to become current. Even so, the petition denial did not deter our client from trying again. He patiently spent the next couple of years improving his credentials and when he was ready, hired us to file another EB-1A petition on his behalf. Roughly 7.5 months after his case was filed, he received notification of case approval.

What was different this time around?

As EB-1A is upheld by a very high standard of law, qualifying for this visa category is easier said than done. We had to demonstrate that our client met at least three out of the 10 requirements set by the USCIS. After carefully re-evaluating his credentials, we presented the following:

We noted the 121 citations to our client’s work, and the 8 times he conducted peer reviews for scientific journals.
To solidify our argument that our client is a leader in the field, we asked him to reach out to other expert protein biochemists to support his EB-1A petition. Six experts agreed to lend their support by signing recommendation letters that verified the importance of his research on studying the means by which a certain bacterium promotes blood clotting and infects the hearts of patients to cause acute infective endocarditis. These letters were incorporated into the EB-1A petition packet and no doubt lent a hand a case approval. As an example, this is what one of our client’s recommenders stated: “With such a strong track record of previous success in the field of biochemistry, it is quite apparent to me that [Client’s] research needs to be allowed to continue in the United States. He has set himself apart from his peers through his impactful studies, and the United States’ technological prowess will undeniably be furthered if his research continues.”

What now?

We are currently helping our client and his spouse prepare their I-485 applications (final step towards a green card). Once everything is in order, we will submit the paperwork on their behalf. In the meantime, we wish our client the best with his continued research efforts, and we thank him for selecting our law firm to help him navigate the elaborate green card process.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.